Question 1

What does peer-reviewed research say about these claims?

Accepted Answer

Bro translation: Mainstream medicine agrees that fat-soluble vitamins can accumulate and that biotin can interfere with some immunoassays, but this clip stretches those facts into a generalized vibe of hidden deficiency and “normal is not optimal” suspicion. The literature does not support using vague depletion alone as evidence that standard labs are missing a problem, and the post does not provide a disease-specific diagnostic basis for escalation.

Question 2

Are Jaban M Moore's credentials legitimate?

Accepted Answer

Jaban Moore presents as a chiropractor, a real state-regulated credential with a narrower musculoskeletal and nervous-system scope. The site nevertheless markets broad disease-cause assessment and systemic detoxification concepts, creating credential inflation through specialty overreach. Stated credentials: none detected. Likely credentials: Chiropractor (DC), DC. Credential inflation detected, a white coat is not the same as an MD/DO license.

Question 3

Is Dr Jaban M Moore a real medical doctor?

Accepted Answer

Jaban M Moore is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Chiropractor (DC).

Question 4

Does Jaban M Moore use Sales Funnel Motive?

Accepted Answer

This turns a health post into lead capture: people are prompted to reveal symptoms publicly, which can be used to move them into DMs, consults, or product recommendations. Likely motive: Generate engagement and route symptomatic viewers into a sales conversation.

Question 5

Does Jaban M Moore use Lab Test Upsell?

Accepted Answer

The post nudges viewers to distrust a normal lab and look for a broader interpretation, a classic setup for recommending more testing or a paid review of results. Likely motive: Create demand for expanded lab interpretation or follow-up testing.

Question 6

Is the claim "The fat soluble ones, A, D, E, and K, are stored in your liver and fat, so their blood …" supported by medical literature?

Accepted Answer

There is strong general evidence that the fat‑soluble vitamins A, D, E and K are stored in the liver and adipose tissue and are eliminated much more slowly than water‑soluble vitamins, allowing accumulation with high chronic intakes and creating a recognized risk of toxicity from oversupplementation. Multiple narrative reviews and clinical summaries on fat‑soluble vitamins state that these vitamins are concentrated and stored in the liver and adipose tissue and that this storage capacity underlies their greater toxicity risk when consumed above tolerable upper intake levels for extended periods, particularly for vitamins A and D. High‑quality clinical and pharmacology references also document hypervitaminosis A and D, including liver injury, hypercalcemia, and other systemic toxicity, most commonly arising from long‑term supplement overuse rather than food alone. Clinical reviews of fat‑soluble vitamin hypo‑ and hypervitaminosis in pediatric patients describe that these vitamins are absorbed with dietary fat, stored in liver and adipose tissue, and that excessive intake can lead to toxicity, reinforcing the influencer’s point that oversupplementation can quietly build harmful levels over time. More detailed physiologic studies of vitamin A show that roughly the vast majority of body vitamin A is stored in the liver while plasma contains only a small fraction of total body stores, and that plasma vitamin A levels are homeostatically regulated over a wide range of liver concentrations, meaning serum levels can appear normal despite significantly depleted or elevated hepatic stores. This directly supports the idea that circulating levels can remain steady while tissue reserves change, and that toxicity or deficiency may not be immediately evident from blood measurements alone. The claim that blood levels of fat‑soluble vitamins can “hold steady long after your reserves fall” is only partially supported and somewhat oversimplified. While vitamin A has well‑documented homeostatic control of serum retinol over a broad range of liver stores, the same degree of serum stability across a wide range of tissue stores is not as clearly established for all fat‑soluble vitamins; for vitamin D, for example, serum 25‑hydroxyvitamin D more closely reflects total body vitamin D status, and declines as stores fall rather than remaining steady over a broad deficiency range. Thus, extrapolating the vitamin A model to all fat‑soluble vitamins may overstate the phenomenon. The claim that these vitamins are “stored in your liver and fat” is broadly correct but incomplete: different fat‑soluble vitamins have distinct storage and distribution patterns (for example, vitamin E in lipoproteins and cell membranes, vitamin K cycling in hepatic clotting pathways), so the description of storage exclusively in liver and fat ignores these nuances. Moreover, while chronic oversupplementation can lead to toxicity, the risk is highly dose‑ and duration‑dependent and varies substantially by vitamin (vitamin A and D having clearer clinical toxicity thresholds, vitamin E and K toxicity being less common and more context‑specific). The influencer’s wording may imply that any moderate long‑term supplementation commonly leads to harmful accumulation, which is not supported by mainstream evidence; toxicity generally arises from sustained intakes above established upper limits rather than from typical recommended doses. Mainstream medical and nutritional consensus is that fat‑soluble vitamins A, D, E and K are absorbed with dietary fat, stored in the body (particularly in the liver and adipose tissue), and cleared slowly, which makes both deficiency and toxicity possible, especially with chronic malabsorption or long‑term intakes above recommended upper limits. For vitamin A, authoritative data show that liver represents the major reservoir and that plasma retinol is tightly regulated, remaining in the normal range across a wide span of hepatic stores until deficiency or toxicity is advanced; this means serum levels are an imperfect early indicator of tissue status and supports caution with high‑dose supplementation. For vitamin D, serum 25‑hydroxyvitamin D is accepted as the best available marker of status and generally falls with depletion and rises with high intake, so blood levels are more directly informative, though toxicity still results from sustained high‑dose use. For vitamins E and K, clinically significant toxicity from supplements is recognized but less common and usually associated with very high doses or specific clinical circumstances (for example, vitamin K interactions with anticoagulants). Overall, mainstream guidance emphasizes that the storage and slow elimination of fat‑soluble vitamins mean that excessive chronic supplementation can indeed build to harmful levels, but safe supplementation within evidence‑based recommended ranges is widely used and not considered inherently dangerous. Clinicians rely on a combination of dietary history Literature verdict: mixed.

Question 7

Is the claim "The water soluble ones like C and most of the B vitamins wash out daily, so they run lo…" supported by medical literature?

Accepted Answer

High-quality evidence supports the core biological parts of the claim for vitamin C and several B vitamins: water-soluble vitamins are generally not stored extensively, excess intake is often excreted in urine, and urinary excretion can reflect recent intake rather than long-term stores. Vitamin C specifically shows saturation kinetics, with low intakes leading to little urinary loss and higher intakes leading to increasing and eventually near-quantitative urinary excretion; major reviews and reference texts note that body pools are limited and that intake around the RDA is sufficient to prevent deficiency in healthy people. For B vitamins, the literature supports that urinary excretion of several B-group vitamins tracks recent dietary intake and that deficiency can develop relatively quickly when intake is inadequate, especially for vitamins with smaller body reserves such as thiamin. The claim is too broad if read as a universal rule for all water-soluble vitamins and all people. Vitamin B12 is water-soluble but is stored in large amounts in the liver and does not typically require steady daily replacement in the same way as vitamin C or thiamin; folate and other B vitamins also vary substantially in storage, turnover, and deficiency timing, so ‘most of the B vitamins wash out daily’ overstates the evidence. The phrase ‘need steady replacement instead of megadoses’ is only partly supported: routine intake to meet requirements is supported, but direct evidence that megadoses are generally unnecessary is stronger as a clinical/nutrition inference than as a universal statement tested in RCTs for every water-soluble vitamin. Also, some water-soluble vitamins can be retained or reabsorbed efficiently at low status, so they do not simply ‘wash out’ at a fixed daily rate. The supplied peer-reviewed index papers are unrelated to vitamin biology and do not materially support or contradict the claim. Mainstream nutrition science agrees that vitamin C and several B vitamins are water-soluble, have limited body storage compared with fat-soluble vitamins, and that excess is often excreted in urine, making regular intake important. It also holds that the claim is oversimplified: vitamin B12 is a major exception because it is stored substantially, and the water-soluble vitamins differ in absorption, storage, turnover, and deficiency risk. The standard view is to meet recommended daily intakes through diet or supplementation when needed, not to use megadoses routinely unless there is a specific clinical indication. Literature verdict: partially supported.

Question 8

Is the claim "Vitamin K2 works alongside vitamin D to steer calcium into bone rather than arteries, w…" supported by medical literature?

Accepted Answer

Vitamin K2 is a cofactor for γ‑carboxylation of osteocalcin and matrix Gla protein, which are involved in directing calcium into bone and inhibiting vascular calcification according to multiple reviews and mechanistic discussions in the academic literature (inferred from the 2017 and later reviews/meta-analyses identified in the search). Several randomized trials and reviews report that vitamin K2 supplementation, often alongside vitamin D and calcium, can modestly improve bone mineral density and fracture-related outcomes in postmenopausal women and other groups, consistent with a role in skeletal calcium handling, though effect sizes are generally small and not always specific to K2 alone. A recent narrative and mechanistic review on vitamins D and K describes them as having potentially synergistic roles in bone metabolism and calcium homeostasis, with vitamin D increasing calcium availability and vitamin K2 activating proteins that bind and utilize calcium in bone (carboxylated osteocalcin), which conceptually supports the idea that they can work together to promote bone mineralization. There are RCTs and meta-analyses showing vitamin K supplementation can lower biochemical markers of vascular calcification (e.g., dephosphorylated-uncarboxylated MGP) and in some pooled analyses slightly slow the progression of coronary artery calcification scores, suggesting a possible protective effect on arteries, although the results are modest and population-specific. Overall, high‑quality evidence supports that vitamin K (especially K2) has beneficial effects on bone health and may favourably influence vascular calcification markers, and that co-supplementation with vitamin D is biologically plausible and supported by some clinical data, but this is far from definitive for “steering calcium” in a strong causal sense. Systematic reviews of vitamin K supplementation and vascular calcification in high‑risk populations such as chronic kidney disease patients conclude that, despite improvements in biochemical markers, there is not yet solid evidence from randomized controlled trials that vitamin K (including K2) meaningfully reduces radiologically measured vascular calcification or hard cardiovascular outcomes; calcification scores often do not change significantly even when surrogate markers improve. Several RCTs in dialysis and CKD cohorts show that vitamin K2 lowers levels of inactive MGP but does not significantly alter aortic or coronary calcification progression over typical trial durations, which contradicts a strong claim that K2 reliably keeps calcium out of arteries. Large guidelines in hypertension, parenteral nutrition, neurology, transfusion medicine, and general clinical nutrition (including ASPEN and ESPEN) do not recommend routine vitamin K2 co‑supplementation with vitamin D specifically to prevent arterial calcification or to “steer calcium” from arteries to bone, which indicates that this mechanism is not accepted as a proven clinical effect in guideline-level evidence. Major evidence syntheses on vitamin K and osteoporosis note that intervention trials are heterogeneous and often inconclusive, with benefits on bone loss and fractures modest and not always reproducible, especially in adults already replete in calcium and vitamin D; this weakens the claim that simply adding K2 to vitamin D fundamentally changes calcium partitioning between bone and arteries. Importantly, there is no high‑quality evidence showing that vitamin D “loading” without K2 systematically increases arterial calcification or backfires clinically, so the warning that supplementing vitamin D alone is harmful in this way overstates the current evidence. The mainstream medical and scientific view is that vitamin D is essential for calcium absorption and bone health and that vitamin K (including K2) plays important roles in activating proteins involved in bone mineralization and inhibition of vascular calcification, but the clinical impact of supplemental vitamin K2, especially in combination with vitamin D, is still under active investigation and not established as a standard of care. Existing RCTs and meta-analyses suggest possible modest benefits of K2 for bone density and fracture risk in some populations, and potential but unproven benefits for slowing vascular calcification in selected high‑risk groups; however, evidence is inconsistent, often limited by small sample sizes, short follow‑up, and reliance on surrogate endpoints rather than major clinical outcomes. Major guidelines in endocrinology, cardiology, and nutrition currently do not recommend routine vitamin K2 co‑supplementation with vitamin D solely to redirect calcium from arteries to bone or to prevent vitamin D‑related vascular harm, reflecting the view that mechanistic plausibility and emerging data are insufficient to justify such broad claims. Standard Literature verdict: mixed.

Advertised	Verdict
Biotin can distort thyroid and hormone results, so a panel can look abnormal when the real culprit is a hair supplement. Rule: RSMo § 331.010(1), (3) Although general nutrition education is authorized, interpreting thyroid or hormone panels and attributing abnormal results to a supplement is systemic medical diagnosis rather than diagnosis of malpositioned articulations or structures directed to neuromusculoskeletal or musculoskeletal health.	Outside scope
Listed service PANS/ PANDAS Rule: RSMo § 331.010(1) Diagnosing PANS or PANDAS concerns systemic neuropsychiatric disease and is not an affirmative authorization to diagnose or treat malpositioned articulations or structures for neuromusculoskeletal or musculoskeletal health.	Outside scope
Listed service Parasites 101 Course Rule: RSMo § 331.010(3) A course focused on parasites would concern infectious or systemic disease rather than an authorized chiropractic activity, unless its content were strictly limited to general hygiene or nutrition education.	Outside scope
Listed service Chronic Fatigue & Brain Fog Rule: RSMo § 331.010(1) Diagnosing or treating chronic fatigue and brain fog as conditions is systemic medical practice and is not affirmatively authorized by Missouri's chiropractic definition.	Outside scope
Listed service Autoimmune Disorders Rule: RSMo § 331.010(1) Diagnosing or treating autoimmune disorders is systemic medical practice outside the statute's affirmative authorization for chiropractic examination, diagnosis, and treatment of malpositioned articulations and structures.	Outside scope
Listed service Lyme & Mold Toxicity Rule: RSMo § 331.010(1) Diagnosing or treating Lyme disease or alleged mold toxicity involves systemic infectious or toxicologic disease and is not authorized as chiropractic practice under Missouri law.	Outside scope

Jaban M Moore alias Vitamin Vaguecaster

Score breakdown

Key findings

Claims & evidence

Manipulation

Commerce & grift map

Credentials & scope

Permitted scope vs advertised

What this license permits

Validated associated properties

Analyzed

Funnel routes (third-party)

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Nudge the Doc Bro

Pick a contact address

What gets sent

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations